1. Home
  2. CASH vs PVLA Comparison

CASH vs PVLA Comparison

Compare CASH & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$78.48

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$150.51

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
PVLA
Founded
1954
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
CASH
PVLA
Price
$78.48
$150.51
Analyst Decision
Buy
Strong Buy
Analyst Count
2
15
Target Price
$107.50
$171.87
AVG Volume (30 Days)
181.5K
158.2K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
0.23%
N/A
EPS Growth
N/A
52.62
EPS
6.29
N/A
Revenue
$839,894,000.00
$42,810,000.00
Revenue This Year
$7.56
N/A
Revenue Next Year
$6.02
$104,350.18
P/E Ratio
$12.58
N/A
Revenue Growth
11.29
65.28
52 Week Low
$65.93
$53.30
52 Week High
$101.26
$161.38

Technical Indicators

Market Signals
Indicator
CASH
PVLA
Relative Strength Index (RSI) 32.06 50.00
Support Level $76.80 $135.68
Resistance Level $85.41 $158.29
Average True Range (ATR) 1.55 6.90
MACD -0.23 -0.31
Stochastic Oscillator 8.10 63.65

Price Performance

Historical Comparison
CASH
PVLA

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: